Gilles Bertschy
Papers
1
Total Citations
1
H-Index
1
About
Gilles Bertschy is a leading figure in biological psychiatry and neuromodulation, with a primary focus on treatment-resistant depression. His work bridges the gap between neuroimaging and personalized brain stimulation, pioneering approaches that move beyond one-size-fits-all protocols. His most notable contribution is a 2025 proof-of-concept randomized trial that demonstrated how individualizing rTMS based on patient-specific perfusion abnormalities can outperform both standard rTMS and tDCS in treatment-resistant depression. This study, already garnering attention with its first citation, represents a paradigm shift toward precision psychiatry—tailoring interventions to the unique neurobiological signatures of each patient. Bertschy’s research has been instrumental in advancing our understanding of how functional brain abnormalities can guide targeted neuromodulation, potentially improving outcomes for patients who have not responded to conventional therapies. His work stands at the intersection of clinical innovation and translational neuroscience, offering a roadmap for the next generation of personalized treatments in mood disorders.
Research Focus
Key Achievements
Top Papers
- 1